Project Coordinator:  A. Rachow MD

In collaboration with FIND-Diagnostics (Geneva), Cepheid (USA), and University College London (UCL), new diagnostics for simple and rapid detection of TB and drug resistance are being developed and evaluated.
Currently, the portfolio in evaluation comprises PCR-based methods directly from smear positive sputum or positive culture, such as GeneXpert® and Hain MTBDRplus®, and the further evaluation of IFN-y release assays (IGRAs) for their performance in detection of childhood TB, and as a markers for treatment course.
In another project, transrenally excreted  mycobacterial DNA is evaluated as biomarker for TB treatment course.
As a gold standard, culture on solid and liquid media is done in our state-of-the art TB laboratory, followed by molecular species determination.
LMU Department for Infectious Diseases and Tropical Medicine provides study design and study coordination within the NIMR-MMRC collaboration, and manages the TB Laboratory through its team members.

You can reach us at:

NIMR - Mbeya Medical Research Center
P.O Box 2410
Hospital Hill rd, Mbeya Tanzania

Tel +255 25 250 3364
Fax +255 25 250 3134

Working hours:
Mon - Fri
08:00 - 17:00 EAT (GMT + 3)

Or send us an email at This email address is being protected from spambots. You need JavaScript enabled to view it.

Our Twitter Feed

NIMRMbeya Dr. Andrew Kitua, NIMR Council Chairperson, appreciating NIMR as an institution leading in medical research that is…
NIMRMbeya Naibu Katibu Mkuu @wizara_afyatz Dkt. Shekalaghe akitoa wito kuhusiana na ugonjwa wa Kifua Kikuu alipohudhuria mkut…
NIMRMbeya The @TBSequel stakeholders' dissemination meeting today at @NIMRHQS under the theme "Towards programmatic diagnosis…
NIMRMbeya As we approach the @TBSequel stakeholders' dissemination meeting ⏳️ Mbeya site screened 611 pts and enroled 424 in…
© 2017 NIMR - Mbeya Medical Research Center